[Prognosis in primary tumors of the central nervous system. A patient material from the Norwegian Radium Hospital 1960-94].
We present the results of a retrospective survey of 1,218 patients treated at the Norwegian Radium Hospital during the years 1980-94 for primary tumours of the central nervous system. Median survival for patients with glioblastoma (n = 492) was 12 months, for patients with anaplastic astrocytoma (n = 83) 25 months, astrocytoma (n = 260) 95 months, oligodendroglioma (n = 85) 74 months, mixed glioma (n = 68) 65 months, and medulloblastoma (n = 53) 109 months. Median survival for patients with brain stem tumours (n = 37) was nine months, while 74% of patients with tumours in the pineal region (n = 38) survived for five years. The histology and localisation of the tumour, as well as age and functional status, are important prognostic factors for survival in patients with primary CNS tumours.
Lote
K
K
Onkologisk avdeling, Det Norske Radiumhospital, Oslo.
Gundersen
S
S
Hannisdal
E
E
Hager
B
B
Stenwig
A E
AE
Tverå
K
K
Berg-Johnsen
J
J
Skullerud
K
K
Bakke
S J
SJ
Hirschberg
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D001254:Astrocytoma / Q000401:mortality* / Q000473:pathology; D001932:Brain Neoplasms / Q000401:mortality* / Q000473:pathology; D002528:Cerebellar Neoplasms / Q000401:mortality* / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D005260:Female; D005910:Glioma / Q000401:mortality* / Q000473:pathology; D006801:Humans; D007223:Infant; D008297:Male; D008527:Medulloblastoma / Q000401:mortality* / Q000473:pathology; D008875:Middle Aged; D009664:Norway / Q000453:epidemiology; D011379:Prognosis
Prognosen ved primaere svulster i sentralnervesystemet. Det Norske Radiumhospitals pasientmateriale 1980-94.